Mission Accomplished – 365 Days on Nerlynx

After surgery, chemotherapy, radiation, and reconstruction, for many HER2-positive breast cancer survivors, our next mission, should we choose to accept it, is to commit to a year of targeted immunotherapy, called Nerlynx. When I accepted the challenge, I decided to document my year on Nerlynx (neratinib) in hopes of helping fellow survivors trying to decideContinue reading “Mission Accomplished – 365 Days on Nerlynx”